These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 7755405)
1. Decrease of 12-hydroxyeicosatetraenoic acid production in mouse lungs following dietary oleic anilide consumption: implications for the toxic oil syndrome. Yoshida SH; Bruenner BA; German JB; Gershwin ME Arch Environ Contam Toxicol; 1995 May; 28(4):524-8. PubMed ID: 7755405 [TBL] [Abstract][Full Text] [Related]
2. Interactions of cis-fatty acids and their anilides with formyl-methionyl-leucyl-phenylalanine, phorbol myristate acetate and dioctanoyl-s,n-glycerol in human leukocytes. Heiskanen K; Ruotsalainen M; Savolainen K Toxicology; 1995 Dec; 104(1-3):113-21. PubMed ID: 8560489 [TBL] [Abstract][Full Text] [Related]
3. Isotype-restricted hyperimmunity in a murine model of the toxic oil syndrome. Bell SA; Hobbs MV; Rubin RL J Immunol; 1992 Jun; 148(11):3369-76. PubMed ID: 1588038 [TBL] [Abstract][Full Text] [Related]
4. Toxic oil syndrome: traceback of the toxic oil and evidence for a point source epidemic. Posada de la Paz M; Philen RM; Borda IA; Sicilia Socias JM; Gómez de la Cámara A; Kilbourne EM Food Chem Toxicol; 1996 Mar; 34(3):251-7. PubMed ID: 8621106 [TBL] [Abstract][Full Text] [Related]
5. Toxic effects of fatty acid anilides on the oxygen defense systems of guinea pig lungs and erythrocytes. Mukherjee S; Ghosh S; Rodgers L; Nayyar T; Desai U; Das SK J Biochem Toxicol; 1994 Feb; 9(1):1-7. PubMed ID: 8151627 [TBL] [Abstract][Full Text] [Related]
6. Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain. Posada de la Paz M; Philen RM; Abaitua Borda I; Diez Ruiz-Navarro M; Abraira Santos V; Pozo Rodríguez F; Pla Mestre R; Pollán Santamaría M; Sicilia Socias JM; Azpeitia Gamazo P Epidemiology; 1994 Jul; 5(4):404-9. PubMed ID: 7918809 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of fatty acid anilides in rabbits and the pathogenesis of the Spanish toxic oil syndrome. Marquet A; Larraga V; Diez JL; Amela C; Rodrigo J; Muñoz E; Pestaña A Experientia; 1984 Sep; 40(9):977-80. PubMed ID: 6205897 [TBL] [Abstract][Full Text] [Related]
9. Toxic oil syndrome, Spain: effect of oleoylanilide on the release of polysaturated fatty acids and lipid peroxidation in rats. Suarez A; Viloria MD; Garcia-Barreno P; Municio AM Arch Environ Contam Toxicol; 1985 Mar; 14(2):131-6. PubMed ID: 3920977 [No Abstract] [Full Text] [Related]
10. Influence of fatty acid anilides present in toxic oils on the metabolism of exogenous arachidonic acid in cultured human endothelial cells. Pich I; López S; Vila L; Lagunas C; de Castellarnau C Toxicology; 1993 Jan; 77(1-2):51-63. PubMed ID: 8442018 [TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase and lipoxygenase arachidonate metabolites synthesized by mouse peritoneal macrophages: in vitro effect of N-phenyllinoleamide from toxic oil samples. Bioque G; Vargas D; Bulbena O; Roselló-Catafau J; Gelpi E Agents Actions; 1993 Jan; 38(1-2):38-43. PubMed ID: 8386901 [TBL] [Abstract][Full Text] [Related]
12. Effects of dietary oil related to the toxic oil syndrome on the lipids of guinea pig liver microsomes. de la Casa E; Pérez-González N; Sánchez-Bernal C; Llanillo M Lipids; 1995 Jun; 30(6):575-9. PubMed ID: 7651086 [TBL] [Abstract][Full Text] [Related]
13. Immunological basis of toxic oil syndrome (TOS). Gallardo S; del Pozo V; Cárdaba B; de Andrés B; Martín-Orozco E; Fernandez JC; Tramón P; Posada M; Abaitua I; Palomino P Toxicology; 1994 Nov; 93(2-3):289-99. PubMed ID: 7974520 [TBL] [Abstract][Full Text] [Related]
14. Neurotransmitter changes in cerebrospinal fluid in the Spanish toxic oil syndrome: human clinical findings and experimental results in mice. del Ser T; Franch O; Portera A; Muradas V; Yebenes JG Neurosci Lett; 1986 Jun; 67(2):135-40. PubMed ID: 2425298 [TBL] [Abstract][Full Text] [Related]
15. Single step thin-layer chromatographic method for quantitation of enzymatic formation of fatty acid anilides. Kaphalia BS; Ansari GA J Chromatogr B Biomed Sci Appl; 1998 Feb; 705(2):269-75. PubMed ID: 9521563 [TBL] [Abstract][Full Text] [Related]
16. Synergistic vascular toxicity and fatty acid anilides in the toxic oil syndrome. Boor PJ; Khan MF; Kaphalia BS; Jerrells TR; Ansari GA J Am Coll Cardiol; 1991 Dec; 18(7):1824-8. PubMed ID: 1960335 [TBL] [Abstract][Full Text] [Related]
17. The toxic oil syndrome: a perspective on immunotoxicological mechanisms. Yoshida SH; German JB; Fletcher MP; Gershwin ME Regul Toxicol Pharmacol; 1994 Feb; 19(1):60-79. PubMed ID: 8159816 [TBL] [Abstract][Full Text] [Related]
18. Dietary menhaden oil lowers plasma prostaglandins and calcium in mice bearing the prostaglandin-producing HSDM1 fibrosarcoma. Tashjian AH; Voelkel EF; Robinson DR; Levine L J Clin Invest; 1984 Dec; 74(6):2042-8. PubMed ID: 6439740 [TBL] [Abstract][Full Text] [Related]
19. Strain-dependent cytokine profile and susceptibility to oleic acid anilide in a murine model of the toxic oil syndrome. Berking C; Hobbs MV; Chatelain R; Meurer M; Bell SA Toxicol Appl Pharmacol; 1998 Feb; 148(2):222-8. PubMed ID: 9473529 [TBL] [Abstract][Full Text] [Related]
20. Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain. Kilbourne EM; Bernert JT; Posada de la Paz M; Hill RH; Abaitua Borda I; Kilbourne BW; Zack MM Am J Epidemiol; 1988 Jun; 127(6):1210-27. PubMed ID: 3369420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]